Clinical outcomes of major clinical events and emergency triheptanoin use in critically ill patients with long-chain fatty acid oxidation disorders

被引：0
|
作者：
Enns, Gregory [1 ]
Marsden, Deborah [2 ]
Ramirez, Antonio Nino [2 ]
Bedrosian, Camille [2 ]
Reineking, Bridget [2 ]
Lu, Xiaoxiao [2 ]
Rahman, Syeda [2 ]
Vockley, Jerry [3 ]
机构：
[1] Stanford Univ, Stanford, CA 94305 USA
[2] Ultragenyx Pharmaceut Inc, Novato, CA USA
[3] Univ Pittsburgh, Pittsburgh, PA USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2021年 / 132卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
eP130
引用
收藏
页码：S86 / S87
页数：3
相关论文
共 50 条
  • [1] Triheptanoin in patients with long-chain fatty acid oxidation disorders: clinical experience in Italy
    Porta, Francesco
    Maiorana, Arianna
    Gragnaniello, Vincenza
    Procopio, Elena
    Gasperini, Serena
    Taurisano, Roberta
    Spada, Marco
    Dionisi-Vici, Carlo
    Burlina, Alberto
    ITALIAN JOURNAL OF PEDIATRICS, 2024, 50 (01)
  • [2] Dietary management and major clinical events in patients with long-chain fatty acid oxidation disorders enrolled in a phase 2 triheptanoin study
    Vockley, Jerry
    Longo, Nicola
    Madden, Megan
    Dwyer, Lauren
    Mu, Yunming
    Chen, Chao-Yin
    Cataldo, Jason
    CLINICAL NUTRITION ESPEN, 2021, 41 : 293 - 298
  • [3] IMPROVEMENTS IN MAJOR CLINICAL EVENTS IN CHILDREN TREATED WITH TRIHEPTANOIN FOR LONG-CHAIN FATTY ACID OXIDATION DISORDERS (LC-FAOD)
    Ray, Kathryn
    Pisani, Laura
    Lu, Xiaoxiao
    Vockley, Jerry
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (04) : 295 - 296
  • [4] EMERGENT USE OF TRIHEPTANOIN FOR TREATMENT OF CARDIOMYOPATHY IN LONG-CHAIN FATTY ACID OXIDATION DISORDERS
    Norris, Marie
    Sullivan, Sarah
    McKean, Kelly N.
    Scott, Anna I.
    Thies, Jenny
    Chang, Irene J.
    Lam, Christina
    Sun, Angela
    Hahn, Sihoun
    Merritt, J. Lawrence, II
    MOLECULAR GENETICS AND METABOLISM, 2019, 127 (03) : 291 - 291
  • [5] Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use
    Kim, Esther S.
    Keam, Susan J.
    DRUGS & THERAPY PERSPECTIVES, 2021, 37 (05) : 187 - 193
  • [6] EMERGENT USE OF TRIHEPTANOIN FOR TREATMENT OF CARDIOMYOPATHY IN LONG-CHAIN FATTY ACID OXIDATION DISORDERS
    Norris, Marie
    Sullivan, Sarah
    McKean, Kelly N.
    Scott, Anna I.
    Thies, Jenny
    Chang, Irene J.
    Lam, Christina
    Sun, Angela
    Hahn, Sihoun
    Merritt, J. Lawrence, II
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 318 - 319
  • [7] Triheptanoin in the management of long-chain fatty acid oxidation disorders: a profile of its use
    Esther S. Kim
    Susan J. Keam
    Drugs & Therapy Perspectives, 2021, 37 : 187 - 193
  • [8] Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
    Thomas Zöggeler
    Katharina Stock
    Monika Jörg-Streller
    Johannes Spenger
    Vassiliki Konstantopoulou
    Miriam Hufgard-Leitner
    Sabine Scholl-Bürgi
    Daniela Karall
    Orphanet Journal of Rare Diseases, 16
  • [9] Long-term experience with triheptanoin in 12 Austrian patients with long-chain fatty acid oxidation disorders
    Zoeggeler, Thomas
    Stock, Katharina
    Joerg-Streller, Monika
    Spenger, Johannes
    Konstantopoulou, Vassiliki
    Hufgard-Leitner, Miriam
    Scholl-Buergi, Sabine
    Karall, Daniela
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [10] Tutorial: Triheptanoin and Nutrition Management for Treatment of Long-Chain Fatty Acid Oxidation Disorders
    Norris, Marie K.
    Scott, Anna I.
    Sullivan, Sarah
    Chang, Irene J.
    Lam, Christina
    Sun, Angela
    Hahn, Sihoun
    Thies, Jenny M.
    Gunnarson, Melissa
    McKean, Kelly N.
    Merritt, J. Lawrence, II
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2021, 45 (02) : 230 - 238
12345